The Living Guidelines: STEMI Recommendations for Angiotensin Receptor Blockers Therapy Suggest Revisions to the CLASS I Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Instructions on How to Edit the Guidelines:
 * Log in
 * Click on "Edit"
 * Type in changes to guidelines
 * Click "Save page" at the bottom of the page

Class I Guidelines

 * 1) Use of angiotensin receptor blockers is recommended in patients who are intolerant of ACE inhibitors and have Heart failure or have had a Myocardial Infarction with LVEF ≤40%. Class I (Level of Evidence: A)
 * 2) It is beneficial to use angiotensin receptor blocker therapy in other patients who are ACE inhibitor intolerant and have hypertension. Class I (Level of Evidence: B)